Thalidomide combined with Trifluridine-Tipiracil Hydrochloride Mixture versus Trifluridine-Tipiracil Hydrochloride Mixture in the third-line or higher treatment of advanced colorectal cancer: a randomized, controlled, multicenter phase II clinical study

ABSTRACT: Interventions: Ttreatment group:Thalidomide;Control group:None Primary outcome(s): toxic and side effect;overall survival;progression-free survival;objective remission rate;Disease Control Rate Study Design: Parallel

DISEASE(S): Advanced Colorectal Cancer

PROVIDER: 2734760 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR